Differential BDNF Responses of Triple Versus Dual Reuptake Inhibition in Neuronal and Astrocytoma Cells as well as in Rat Hippocampus and Prefrontal Cortex
Authors:
Open Access
- 13 May 2012
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 48 (1) , 167-175
Abstract
Monoamine reuptake inhibitors increase brain-derived neurotrophic factor (BDNF) activity, and this growth factor is regarded as an interesting target for developing new antidepressant drugs. The aims of this study were to evaluate whether monoaminergic reuptake inhibition increases BDNF in vivo and in vitro as predicted by the neurotrophic hypothesis of depression, and whether triple reuptake inhibition has a superior BDNF response compared to dual reuptake inhibition. Twenty-one days of oral treatment (30 mg/kg) with the dual serotonin/noradrenaline reuptake inhibitor duloxetine or the triple serotonin/noradrenaline/dopamine reuptake inhibitor DOV 216,303 restored BDNF protein levels in the rat hippocampus, which were initially decreased due to injection stress. The prefrontal cortex contained increased BDNF levels only after DOV 216,303 treatment. In vitro, neither duloxetine nor DOV 216,303 altered intracellular BDNF levels in murine HT22 neuronal cells. In contrast, BDNF release was more effectively decreased following treatment with DOV 216,303 in these cells. In rat C62B astrocytomas, both antidepressants increased intracellular BDNF levels at their highest nontoxic concentration. C62B astrocytomas did not release BDNF, even after antidepressant treatment. Increased BDNF levels support the neurotrophic hypothesis of depression, but our findings do not clearly evidence that the BDNF response after triple reuptake inhibitors is more effective than after dual reuptake inhibitors. Moreover, the data suggest that the role of BDNF in neurons and astrocytes is complex and likely depends on factors including specificity of cell types in different brain regions, cell–cell interactions, and different mechanisms of action of antidepressants used.Keywords
This publication has 55 references indexed in Scilit:
- Fluoxetine treatment induces dose dependent alterations in depression associated behavior and neural plasticity in female miceNeuroscience Letters, 2010
- Antidepressants increase neural progenitor cells in the human hippocampusNeuropsychopharmacology, 2009
- Neurogenesis-Dependent and -Independent Effects of Fluoxetine in an Animal Model of Anxiety/DepressionNeuron, 2009
- Acute Hippocampal Brain-Derived Neurotrophic Factor Restores Motivational and Forced Swim Performance After CorticosteroneBiological Psychiatry, 2008
- Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatmentsBrain Research, 2008
- Selective Loss of Brain-Derived Neurotrophic Factor in the Dentate Gyrus Attenuates Antidepressant EfficacyBiological Psychiatry, 2008
- BDNF Level in the Rat Prefrontal Cortex Increases Following Chronic but Not Acute Treatment with Duloxetine, a Dual Acting Inhibitor of Noradrenaline and Serotonin Re-uptakeCellular and Molecular Neurobiology, 2008
- The yin and yang of neurotrophin actionNature Reviews Neuroscience, 2005
- “Broad spectrum” antidepressants: Is more better for the treatment of depression?Life Sciences, 2003
- Astroglia induce neurogenesis from adult neural stem cellsNature, 2002